Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

OncoSolutions

OncoSolutions
2016 FOUNDED
PRIVATE STATUS
1-10 EMPLOYEES
Grant LATEST DEAL TYPE
$25K LATEST DEAL AMOUNT
2 INVESTORS
Description

Developer of a drug screening technology designed to generate 3D cancer cell models that mimic tumours in the body. The company's technology is a robotic and automated technology that meets industry standards for robustness and can accommodate 16 times the number of drugs than existing 3D model methods, enabling clients to to reduce animal drug failure rates by half.

Ownership Status
Privately Held (backing)
Financing Status
Angel-Backed
Primary Industry
Other Healthcare Technology Systems
Other Industries
Other Pharmaceuticals and Biotechnology
Other Healthcare Services
Primary Office
  • 526 South Main Street
  • Suite 818
  • Akron, OH 44311
  • United States
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore OncoSolutions’s full profile, request a free trial.

OncoSolutions Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Grant 12-Sep-2017 $25K 00000 Completed Startup
2. Grant 31-Mar-2017 00000 00000 Completed Startup
1. Angel (individual) $240K $240K Completed Startup
To view this company’s complete deal history including valuation and funding, request access »

OncoSolutions Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
Innovation Fund America Not-For-Profit Venture Capital 000 0000 000000 0
Ohio Third Frontier Lender/Debt Provider 000 0000 000000 0

OncoSolutions Executive Team (3)

Name Title Board
Seat
Contact
Info
Stephanie Ham Ph.D Co-Founder & Chief Executive Officer
Elyse Ball JD Co-Founder & Chief Operating Officer
Hossein Tavana Ph.D Co-Founder & Chief Technical Officer